Form 8-K - Current report:
SEC Accession No. 0001628280-23-014368
Filing Date
2023-05-01
Accepted
2023-05-01 09:39:02
Documents
13
Period of Report
2023-04-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K APRIL 27 2023 pfe-20230427.htm   iXBRL 8-K 83716
  Complete submission text file 0001628280-23-014368.txt   264697

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20230427.xsd EX-101.SCH 2733
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20230427_def.xml EX-101.DEF 15407
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20230427_lab.xml EX-101.LAB 30338
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20230427_pre.xml EX-101.PRE 16025
7 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20230427_htm.xml XML 14687
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 23870745
SIC: 2834 Pharmaceutical Preparations